CSL Limited

ASX (AUD): CSL Limited (CSL)

Last Price

252.92

Today's Change

-3.88 (1.51%)

Day's Change

252.33 - 257.19

Trading Volume

720,527

Overview

Market Cap

122 Billion

Shares Outstanding

484 Million

Avg Volume

810,094

Avg Price (50 Days)

263.47

Avg Price (200 Days)

285.75

PE Ratio

29.14

EPS

8.68

Earnings Announcement

19-Aug-2025

Previous Close

256.80

Open

257.00

Day's Range

252.33 - 257.19

Year Range

246.2 - 313.55

Trading Volume

720,527

Price Change Highlight

1 Day Change

5 Day Change

1 Month Change

3 Month Change

6 Month Change

Ytd Change

1 Year Change

3 Year Change

5 Year Change

10 Year Change

Max Change

News and Blogs

No result.

Company Profile

Sector: Healthcare - Healthcare

Industry: Biotechnology

Description:

CSL Limited researches, develops, manufactures, markets, and distributes biopharmaceutical and allied products in Australia, the United States, Germany, the United Kingdom, Switzerland, China, and internationally. The company operates through two segments, CSL Behring and CSL Seqirus. The CSL Behring segment offers plasma therapies, such as plasma products and recombinants. This segment also conducts research on plasma and non-plasma therapies; and receives license and royalty from the commercialization of intellectual property. The CSL Seqirus segment manufactures and distributes non-plasma biotherapeutic products; and develops influenza related products. CSL Limited was founded in 1916 and is headquartered in Parkville, Australia.

Discussions
Be the first to like this. Showing 0 of 0 comments

Post a Comment